GlassScriptPhysician profile
Jay K Bhama
NPI 1760491989
$192,485.00
in general payments reported to CMS, 2019-2025
33 companies · $7,044 in 2025
The $7,044 reported for 2025 was more than what 87% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $3,874 · 2021: $9,196 · 2022: $90K · 2023: $30K · 2024: $15K · 2025: $7,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $30K · Food and Beverage: $12K · Travel and Lodging: $6,477 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $30,450.00 |
| Food and Beverage | $12,294.46 |
| Travel and Lodging | $6,477.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,437.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $115,966.69 | 2019-2025 | Impella |
| Livanova USA, INC. | $36,879.51 | 2019-2024 | Protekduo, Lifesparc |
| Abbott Laboratories | $22,610.60 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| Atricure, INC. | $3,583.42 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Edwards Lifesciences Corporation | $2,397.36 | 2019-2025 | Mitris Resilia Mitral Valve, Hemosphere, Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $2,026.69 | 2019-2020 | |
| Stryker Corporation | $1,565.25 | 2021-2025 | Na |
| Davol INC. | $1,552.43 | 2022-2025 | Tridyne Vascular Sealant, Arista Ah Flexitip, Arista |
| Baxter Healthcare | $1,283.65 | 2019-2025 | Recothrom, Coseal, Preveleak |
| Cvrx, INC. | $1,026.15 | 2023-2025 | Barostim Neo System |
| Boston Scientific Corporation | $623.43 | 2019-2025 | General - Therapies, General - Balloon Catheters, General - Ultrasound |
| Kls-Martin L.P. | $544.13 | 2021-2022 | |
| Angiodynamics, INC. | $405.18 | 2020-2022 | |
| Haemonetics Corporation | $397.53 | 2020-2023 | Teg6s Hemostasis System |
| Ethicon US, LLC | $372.05 | 2019-2025 | Echelon; Endopath, N/A, Echelon Flex |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $199.53 | 2019-2024 | Cor-Knot, Cor Knot |
| Medtronic, INC. | $163.37 | 2024-2025 | Penditure, Vitalflow Console |
| Teleflex LLC | $128.81 | 2021 | |
| Zimmer Biomet Holdings, INC. | $109.40 | 2020 | |
| Z-Medica, LLC | $104.72 | 2020 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $104.54 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $88.72 | 2024 | Farxiga |
| Terumo Medical Corporation | $55.24 | 2025 | Metacross Otw, R2p Misago, Glidesheath Slender |
| Becton, Dickinson and Company | $54.95 | 2022 | |
| Biotronik INC. | $52.02 | 2019 | |
| Medical Device Business Services, INC. | $48.53 | 2024 | Vistaseal |
| Clearflow INC. | $42.23 | 2020 | |
| Elutia, INC. | $26.69 | 2019 | |
| W. L. Gore & Associates, INC. | $18.73 | 2019 | |
| Medistim USA, INC. | $16.79 | 2019 | |
| Philips North America LLC | $13.52 | 2025 | Labosys |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.91 | 2019 | |
| Pfizer INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Bhama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.